<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Martindale JJ</submitter><funding>NIA NIH HHS</funding><funding>NHLBI NIH HHS</funding><pagination>26-37</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3920738</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>67</volume><pubmed_abstract>Myocardial ischemia/reperfusion (I/R) injury is a major clinical problem leading to cardiac dysfunction and myocyte death. It is widely held that I/R causes damage to membrane phospholipids, and is a significant mechanism of cardiac I/R injury. Molecular dissection of sarcolemmal damage in I/R, however, has been difficult to address experimentally. We studied here cardiac I/R injury under conditions targeting gain- or loss-of sarcolemma integrity. To implement gain-in-sarcolemma integrity during I/R, synthetic copolymer-based sarcolemmal stabilizers (CSS), including Poloxamer 188 (P188), were used as a tool to directly stabilize the sarcolemma. Consistent with the hypothesis of sarcolemmal stabilization, cellular markers of necrosis and apoptosis evident in untreated myocytes were fully bl</pubmed_abstract><journal>Journal of molecular and cellular cardiology</journal><pubmed_title>Uncoupling of increased cellular oxidative stress and myocardial ischemia reperfusion injury by directed sarcolemma stabilization.</pubmed_title><pmcid>PMC3920738</pmcid><funding_grant_id>R01 HL059301</funding_grant_id><funding_grant_id>R01 AG034107</funding_grant_id><funding_grant_id>R01 HL122323</funding_grant_id><pubmed_authors>Martindale JJ</pubmed_authors><pubmed_authors>Metzger JM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Uncoupling of increased cellular oxidative stress and myocardial ischemia reperfusion injury by directed sarcolemma stabilization.</name><description>Myocardial ischemia/reperfusion (I/R) injury is a major clinical problem leading to cardiac dysfunction and myocyte death. It is widely held that I/R causes damage to membrane phospholipids, and is a significant mechanism of cardiac I/R injury. Molecular dissection of sarcolemmal damage in I/R, however, has been difficult to address experimentally. We studied here cardiac I/R injury under conditions targeting gain- or loss-of sarcolemma integrity. To implement gain-in-sarcolemma integrity during I/R, synthetic copolymer-based sarcolemmal stabilizers (CSS), including Poloxamer 188 (P188), were used as a tool to directly stabilize the sarcolemma. Consistent with the hypothesis of sarcolemmal stabilization, cellular markers of necrosis and apoptosis evident in untreated myocytes were fully bl</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014 Feb</publication><modification>2025-04-05T11:49:47.768Z</modification><creation>2019-03-27T01:21:37Z</creation></dates><accession>S-EPMC3920738</accession><cross_references><pubmed>24362314</pubmed><doi>10.1016/j.yjmcc.2013.12.008</doi></cross_references></HashMap>